What is the recommended treatment for herpes simplex meningitis with a negative cerebrospinal fluid (CSF) polymerase chain reaction (PCR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Herpes Simplex Meningitis with Negative CSF PCR

Despite a negative CSF PCR result, acyclovir should be continued for 14-21 days in patients with clinically suspected herpes simplex meningitis, as false-negative PCR results can occur, particularly early in the disease course. 1

Diagnostic Considerations with Negative PCR

  • Initial CSF PCR can be negative in HSV encephalitis/meningitis, especially if performed early in the illness (<72 hours after symptom onset) or late after viral clearance has begun 1
  • False-negative PCR results have been documented in confirmed cases of HSV encephalitis, including cases with two consecutive negative PCR results 2, 3
  • MRI findings consistent with HSV infection (particularly temporal lobe involvement) should prompt continued treatment despite negative PCR results 3, 4
  • CSF pleocytosis, elevated protein, and reduced glucose in the appropriate clinical context should maintain suspicion for HSV meningitis even with negative PCR 5

Treatment Algorithm

Initial Management

  • Intravenous acyclovir (10 mg/kg three times daily) should be started immediately when HSV meningitis/encephalitis is suspected, without waiting for confirmatory test results 1
  • Dose adjustment is required in patients with renal impairment 1

When to Continue Treatment Despite Negative PCR

Continue acyclovir if ANY of the following apply:

  • Clinical suspicion remains high despite negative PCR 1, 2
  • CSF was sampled <72 hours after symptom onset 1
  • MRI shows findings consistent with HSV infection (particularly temporal lobe involvement) 3, 4
  • CSF shows pleocytosis or other abnormalities consistent with viral meningitis 1
  • Patient has altered consciousness or other neurological symptoms 1

When Treatment Can Be Safely Discontinued

Acyclovir can be stopped in immunocompetent patients if:

  • An alternative diagnosis has been established 1
  • HSV PCR in CSF is negative on two occasions 24-48 hours apart, AND MRI is not characteristic for HSV infection 1
  • HSV PCR in CSF is negative once >72 hours after symptom onset, WITH normal level of consciousness, normal MRI (performed >72 hours after symptom onset), AND CSF white cell count <5×10^6/L 1

Duration of Treatment

  • For confirmed HSV meningitis/encephalitis: 14-21 days of intravenous acyclovir 1
  • Consider repeating CSF examination at the end of treatment to confirm clearance of virus by PCR 1
  • If CSF remains positive for HSV by PCR at the end of treatment, continue intravenous acyclovir with weekly PCR until negative 1

Adjunctive Therapy

  • Corticosteroids are not routinely recommended for HSV meningitis/encephalitis while awaiting results of ongoing clinical trials 1
  • Corticosteroids may be considered in cases with significant cerebral edema, brain shift, or raised intracranial pressure under specialist supervision 1

Special Considerations

  • Negative PCR should be interpreted with caution, especially when clinical suspicion is high 2, 3
  • Early treatment with acyclovir significantly reduces mortality and morbidity (mortality decreases to 8% if therapy is initiated <4 days after symptom onset) 1
  • Relapse of HSV encephalitis has been reported after completion of acyclovir therapy, with rates as high as 5% in adults 1
  • Valaciclovir is not recommended as initial therapy due to inadequate CSF penetration, but may have a role in ongoing treatment after initial IV acyclovir, particularly in patients with HSV still detectable in CSF after 2-3 weeks 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Update on herpes simplex encephalitis.

Reviews in neurological diseases, 2004

Research

Acute hydrocephalus secondary to herpes simplex type II meningitis.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.